Flash e-reader

 Go to e-reader chapter








Table 5.10a

Unadjusted Graft Survival, Deceased Donor non-ECD Kidney Transplants

Survival at 3 Months, 1 Year, 5 Years, and 10 Years

  3 Months 1 Year 5 Years 10 Years
(Tx 2007 - 2008) (Tx 2007 - 2008) (Tx 2003 - 2008) (Tx 1998 - 2008)
N % Std. Err. N % Std. Err. N % Std. Err. N % Std. Err.
Total All 16,520 96.1% 0.1% 16,520 92.8% 0.2% 47,216 73.2% 0.3% 81,283 47.6% 0.3%
Primary Diagnosis Glomerular Diseases 4,029 96.6% 0.3% 4,029 94.0% 0.4% 11,995 74.8% 0.5% 21,486 52.3% 0.5%
Diabetes 3,811 96.0% 0.3% 3,811 91.1% 0.5% 10,531 68.5% 0.6% 17,464 36.4% 0.6%
Hypertensive Nephrosclerosis 4,055 95.9% 0.3% 4,055 92.6% 0.4% 10,643 70.6% 0.6% 16,601 42.5% 0.7%
Polycystic Kidneys 1,366 97.5% 0.4% 1,366 95.7% 0.6% 3,908 83.9% 0.7% 7,036 63.3% 0.9%
Tubular and Interstitial Diseases 764 96.6% 0.7% 764 93.2% 0.9% 2,447 72.8% 1.1% 4,468 51.2% 1.1%
Renovascular & Other Vascular Diseases 466 95.3% 1.0% 466 91.2% 1.3% 1,805 75.4% 1.2% 3,713 42.8% 1.3%
Congenital, Rare Familial, & Metabolic Disorders 580 95.5% 0.9% 580 92.9% 1.1% 1,581 75.1% 1.4% 2,560 54.2% 1.6%
Neoplasms 61 93.4% 3.2% 61 93.4% 3.2% 167 73.7% 4.5% 258 41.9% 5.4%
Other 1,297 95.5% 0.6% 1,297 92.8% 0.7% 3,728 75.1% 0.9% 6,566 50.3% 1.0%
Unknown 91 89.0% 3.3% 91 84.6% 3.8% 411 71.8% 2.5% 1,131 51.1% 2.0%


Source: OPTN/SRTR Data as of October 1, 2010.

(+) = Values not determined due to insufficient follow-up. (-) = Values not determined since there were no transplants in the category.

Cohorts are transplants performed during the years listed at the top of the table.

Graft survival follows individual transplants until graft failure.

Counts for patient and graft survival are different because a patient may have more than one transplant for a type of organ.

Center volume = Center's yearly transplants performed during the base period, based on kidney and kidney-pancreas transplants.

Multi-organ transplants are excluded.

Dialysis needed within first week excludes patients whose graft failed before the end of the week.